Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?

Verleye, Leen; Ottevanger, Petronella B.; Kristensen, Gunnar B.; Ehlen, Tom; Johnson, Nick; Burg, M.E.L. van der; Reed, Nick; Verheijen, René H.M.; Gaarenstroom, Katja N.; Mosgaard, Berit Jul; Seoane, Jose Miguel; Velden, J. van der; Lotocki, Robert; Graaf, Winette van der; Penninckx, Björn; Coens, Corneel; Stuart, Gavin; Vergote, Ignace

doi:10.1016/j.ejca.2010.08.008

Cited by 32 publications

(5 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Audits can bring out the inadequacies in the histopathology reports. [ 4 5 ] It is well recognized that standardization in cancer reporting improves the completeness and quality of the reports. [ 6 7 8 ] With respect to similar audits from our country, we came across an audit of rectal carcinoma reports by Nambiar et al .…”

Section: Discussionmentioning

confidence: 99%

An audit of histopathology reports of carcinoma endometrium

Deodhar

Rekhi

Menon

et al. 2015

Journal of Postgraduate Medicine

View full text Add to dashboard Cite

Background:The aim was to see, compliance to minimum data information in carcinoma endometrium reports, in a team of 13 pathologists, and also to analyze these parameters e.g. tumor size, type, grade, depth of myometrial invasion, lymph node yield, pTNM stage etc.Materials and Methods:Reports of 114 cases of carcinoma endometrium, that were operated in-house during the years 2008 to 2010 were analyzed from the files of the Pathology department of our hospital.Results:The median age was 58.04 years and median tumor size was 4 cm. Endometrioid adenocarcinoma was the most common type (82.5%), followed by malignant mixed Mullerian tumor (MMMT) (6.1%) and Serous carcinoma (3.5%). Grade 2 was the commonest tumor grade (42.1%). Less than half of myometrial invasion was seen in 50% of the cases and more than half of the myometrial invasion was seen in 46.5% of cases. (Information was not available in four cases). Parametrial involvement was seen in 5.3% cases. The pTNM stage was not mentioned in 71.9% reports. The median lymph node yield was 15.Conclusion:The compliance to adhere to and to provide minimum data information in carcinoma endometrium reports is generally good. Lymph node yield is reasonable. Mentioning of pTNM staging is to be done more meticulously. Use of proformas/checklists is recommended.

show abstract

Section: Discussionmentioning

confidence: 99%

An audit of histopathology reports of carcinoma endometrium

Deodhar

Rekhi

Menon

et al. 2015

Journal of Postgraduate Medicine

View full text Add to dashboard Cite

show abstract

“…The problems of interpretation errors and missing data in cancer pathology reports have been analyzed and presented in several international studies [1,2,18,19]. Reasons responsible for the lack of complete reporting could be various levels of knowledge of the reporting pathologists, e.g.…”

Section: Discussionmentioning

confidence: 99%

“…Standardized pathology processes are also important in the framework of clinical trials. The clinical trial based on pathology sections with clear guidelines present more reliable results, reduced variability and less errors [1]. However, we should bear in mind that use of a checklist by itself does not guarantee an adequate report, since about 12% of reports in the study by Idowu et al [19] and up to 165 of the reports in the study by Srigley et al [22] did not have all the mandated elements despite the routine use of synoptic reports/checklists.…”

Section: Discussionmentioning

confidence: 99%

“…A large audit of pathology reports of 479 cases from 40 institutions in 11 countries checked for quality report indicators in advanced ovarian, Fallopian tube and peritoneal cancers revealed that basic pathological data were missing in a substantial number of reports with possible adverse consequences on the quality of cancer care. The quality of reports differs significantly by country [1]. Some clinicians at referring institutions were faced with therapeutic dilemmas due to incomplete pathology reports.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Functional Assessment of Synoptic Pathology Reporting for Ovarian Cancer

Słodkowska¹,

Cierniak²,

Patera³

et al. 2016

Pathobiology

View full text Add to dashboard Cite

Background: Ovarian cancer has one of the highest death/incidence rates and is commonly diagnosed at an advanced stage. In the recent WHO classification, new histotypes were classified which respond differently to chemotherapy. The e-standardized synoptic cancer pathology reports offer the clinicians essential and reliable information. The aim of our project was to develop an e-template for the standardized synoptic pathology reporting of ovarian carcinoma [based on the checklist of the College of American Pathologists (CAP) and the recent WHO/FIGO classification] to introduce a uniform and improved quality of cancer pathology reports. A functional and qualitative evaluation of the synoptic reporting was performed. Methods: An indispensable module for e-synoptic reporting was developed and integrated into the Hospital Information System (HIS). The electronic pathology system used a standardized structure with drop-down lists of defined elements to ensure completeness and consistency of reporting practices with the required guidelines. All ovarian cancer pathology reports (partial and final) with the corresponding glass slides selected from a 1-year current workflow were revised for the standard structured reports, and 42 tumors [13 borderline tumors and 29 carcinomas (mainly serous)] were included in the study. Results: Analysis of the reports for completeness against the CAP checklist standard showed a lack of pTNM staging in 80% of the partial or final unstructured reports; ICD-O coding was missing in 83%. Much less frequently missed or unstated data were: ovarian capsule infiltration, angioinvasion and implant evaluation. The e-records of ovarian tumors were supplemented with digital macro- and micro-images and whole-slide images. Conclusions: The e-module developed for synoptic ovarian cancer pathology reporting was easily incorporated into HIS.CGM CliniNet and facilitated comprehensive reporting; it also provided open access to the database for concerned recipients. The e-synoptic pathology reports appeared more accurate, clear and conclusive than traditional narrative reports. Standardizing structured reporting and electronic tools allows open access and downstream utilization of pathology data for clinicians and tumor registries.

show abstract

“…The dominant method of reporting such findings is the narrative report, which is a free text, descriptive account of the procedure, findings, and proposed treatment. Research has demonstrated, across settings and diseases, these types of reports inconsistently and incompletely provide the information required to understand the disease and make informed care decisions [2-7]. …”

Section: Introductionmentioning

confidence: 99%

Multi-level factors influence the implementation and use of complex innovations in cancer care: a multiple case study of synoptic reporting

et al. 2014

View full text Add to dashboard Cite

BackgroundThe implementation of innovations (i.e., new tools and practices) in healthcare organizations remains a significant challenge. The objective of this study was to examine the key interpersonal, organizational, and system level factors that influenced the implementation and use of synoptic reporting tools in three specific areas of cancer care.MethodsUsing case study methodology, we studied three cases in Nova Scotia, Canada, wherein synoptic reporting tools were implemented within clinical departments/programs. Synoptic reporting tools capture and present information about a medical or surgical procedure in a structured, checklist-like format and typically report only items critical for understanding the disease and subsequent impacts on patient care. Data were collected through semi-structured interviews with key informants, document analysis, nonparticipant observation, and tool use/examination. Analysis involved production of case histories, in-depth analysis of each case, and a cross-case analysis. Numerous techniques were used during the research design, data collection, and data analysis stages to increase the rigour of this study.ResultsThe analysis revealed five common factors that were particularly influential to implementation and use of synoptic reporting tools across the three cases: stakeholder involvement, managing the change process (e.g., building demand, communication, training and support), champions and respected colleagues, administrative and managerial support, and innovation attributes (e.g., complexity, compatibility with interests and values). The direction of influence (facilitating or impeding) of each of these factors differed across and within cases.ConclusionsThe findings demonstrate the importance of a multi-level contextual analysis to gaining both breadth and depth to our understanding of innovation implementation and use in health care. They also provide new insights into several important issues under-reported in the literature on moving innovations into healthcare practice, including the role of middle managers in implementation efforts and the importance of attending to the interpersonal aspects of implementation.Electronic supplementary materialThe online version of this article (doi:10.1186/s13012-014-0121-0) contains supplementary material, which is available to authorized users.

show abstract

Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?

Cited by 32 publications

References 41 publications

An audit of histopathology reports of carcinoma endometrium

An audit of histopathology reports of carcinoma endometrium

Functional Assessment of Synoptic Pathology Reporting for Ovarian Cancer

Multi-level factors influence the implementation and use of complex innovations in cancer care: a multiple case study of synoptic reporting

Contact Info

Product

Resources

About